FdaApplication
NDA 205583
Identifiers
- fda_app_no: NDA205583
Properties
| Property | Value |
|---|---|
| applicant_name | SUN PHARMACEUTICAL INDUSTRIES LTD |
| application_type | NDA |
| approval_date | 2014-01-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DESVENLAFAXINE | DESVENLAFAXINE FUMARATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| DESVENLAFAXINE | DESVENLAFAXINE FUMARATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE;ORAL |
2 products